Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Lung/Thoracic Oncology

Association between neuronal autoantibodies and cognitive impairment in patients with lung cancer

JAMA | Sep 22, 2021 Lung/Thoracic Oncology

Efficacy and prognosis of first-line EGFR-tyrosine kinase inhibitor treatment in older adults including poor performance status patients with EGFR -mutated non-small-cell lung cancer

Cancer Management and Research | Sep 18, 2021 Lung/Thoracic Oncology

Lung cancer as a subsequent malignant neoplasm in survivors of childhood cancer

Cancer Epidemiology, Biomarkers & Prevention | Sep 18, 2021 Lung/Thoracic Oncology

Lung and lymph node metastases from hepatocellular carcinoma: Comparison of pathological aspects

Liver International | Sep 12, 2021 Lung/Thoracic Oncology

Ensartinib vs crizotinib for patients with ALK -positive NSCLC

JAMA | Sep 09, 2021 Lung/Thoracic Oncology

Comparison of different EGFR gene mutation status in patients with metastatic non-small lung cancer after first-line EGFR-TKIs therapy and analyzing its relationship with efficacy and prognosis

Cancer Management and Research | Sep 07, 2021 Lung/Thoracic Oncology

A prospective, phase II trial of monotherapy with low-dose afatinib for patients with EGFR, mutation-positive, non-small cell lung cancer: Thoracic Oncology Research Group 1632

Lung Cancer | Sep 03, 2021 Lung/Thoracic Oncology

Clinical impact of pembrolizumab combined with chemotherapy in elderly patients with advanced non-small-cell lung cancer

Lung Cancer | Sep 03, 2021 Lung/Thoracic Oncology

Single- vs multifraction stereotactic ablative body radiotherapy for pulmonary oligometastases

JAMA | Sep 02, 2021 Lung/Thoracic Oncology

Sarcopenia on preoperative chest computed tomography predicts cancer‐specific and all‐cause mortality following pneumonectomy for lung cancer: A multicenter analysis

Cancer Medicine | Aug 23, 2021 Lung/Thoracic Oncology

« Prev 1 2 3 4 5 6 7 … 149 Next »

Association between neuronal autoantibodies and cognitive impairment in patients with lung cancer

Efficacy and prognosis of first-line EGFR-tyrosine kinase inhibitor treatment in older adults including poor performance status patients with EGFR -mutated non-small-cell lung cancer

Lung cancer as a subsequent malignant neoplasm in survivors of childhood cancer

Lung and lymph node metastases from hepatocellular carcinoma: Comparison of pathological aspects

Ensartinib vs crizotinib for patients with ALK -positive NSCLC

Comparison of different EGFR gene mutation status in patients with metastatic non-small lung cancer after first-line EGFR-TKIs therapy and analyzing its relationship with efficacy and prognosis

A prospective, phase II trial of monotherapy with low-dose afatinib for patients with EGFR, mutation-positive, non-small cell lung cancer: Thoracic Oncology Research Group 1632

Clinical impact of pembrolizumab combined with chemotherapy in elderly patients with advanced non-small-cell lung cancer

Single- vs multifraction stereotactic ablative body radiotherapy for pulmonary oligometastases

Sarcopenia on preoperative chest computed tomography predicts cancer‐specific and all‐cause mortality following pneumonectomy for lung cancer: A multicenter analysis

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Anaesthetic Management in Obese Patients

Association between neuronal autoantibodies and cognitive impairment in patients with lung cancer

Efficacy and prognosis of first-line EGFR-tyrosine kinase inhibitor treatment in older adults including poor performance status patients with EGFR -mutated non-small-cell lung cancer

Lung cancer as a subsequent malignant neoplasm in survivors of childhood cancer

Lung and lymph node metastases from hepatocellular carcinoma: Comparison of pathological aspects

Ensartinib vs crizotinib for patients with ALK -positive NSCLC

Comparison of different EGFR gene mutation status in patients with metastatic non-small lung cancer after first-line EGFR-TKIs therapy and analyzing its relationship with efficacy and prognosis

A prospective, phase II trial of monotherapy with low-dose afatinib for patients with EGFR, mutation-positive, non-small cell lung cancer: Thoracic Oncology Research Group 1632

Clinical impact of pembrolizumab combined with chemotherapy in elderly patients with advanced non-small-cell lung cancer

Single- vs multifraction stereotactic ablative body radiotherapy for pulmonary oligometastases

Sarcopenia on preoperative chest computed tomography predicts cancer‐specific and all‐cause mortality following pneumonectomy for lung cancer: A multicenter analysis

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Anaesthetic Management in Obese Patients

Select Specialty

Select Topic